Maximizing Outcomes in Treating Acute Migraine
Clinical trial NCT03896009 · COMPLETED
Trial details
- NCT number
- NCT03896009
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-04
- Primary completion
- 2019-12-10
- Enrollment
- 1594
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.